SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
5.14
+0.13 (2.59%)
Jul 28, 2026, 11:24 AM EDT - Market open
SciSparc Revenue
In the year 2025, SciSparc had annual revenue of $856.00K, down -34.46%. SciSparc had revenue of $856.00K in the quarter ending December 31, 2025, a decrease of -34.46%.
Revenue (ttm)
$856.00K
Revenue Growth
-34.46%
P/S Ratio
3.36
Revenue / Employee
$285,333
Employees
3
Market Cap
2.95M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 856.00K | -450.00K | -34.46% |
| Dec 31, 2024 | 1.31M | -1.57M | -54.64% |
| Dec 31, 2023 | 2.88M | 1.53M | 113.73% |
| Dec 31, 2022 | 1.35M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HCW Biologics | 6.59M |
| GeoVax Labs | 852.28K |
| Onconetix | 735.20K |
| Virax Biolabs Group | 12.42K |
| Creative Medical Technology Holdings | 3.00K |
SPRC News
- 1 day ago - SciSparc to target agentic artificial intelligence market - TheFly
- 1 day ago - SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity - GlobeNewsWire
- 13 days ago - SciSparc initiates SCI-110 clinical trial in Germany - TheFly
- 13 days ago - SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome - GlobeNewsWire
- 13 days ago - NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome - TheNewswire
- 25 days ago - NeuroThera Labs Announces Upsize to Private Placement - TheNewswire
- 27 days ago - NeuroThera Labs Announces C$5,000,000 Private Placement of Units - TheNewswire
- 7 weeks ago - SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum - GlobeNewsWire